Fidelity National Financial, Inc. (FNF) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US31620R3030
Fidelity National Financial, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 14.45 bn USD |
| EBIT | 1.43 bn USD |
| Net income | 602.00 m USD |
| Diluted EPS – continuing operations | 2.21 USD |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fidelity National Financial, Inc.
Fidelity National Financial, Inc., together with its subsidiaries, provides various insurance products in the United States. It operates through Title, F&G, and Corporate and Other segments. The company offers title insurance, escrow, and other title related services, including trust activities, trustee sales guarantees, recordings and reconveyances, and home warranty products. It also provides technology and transaction services to the real estate and mortgage industries; and mortgage transaction services, including title-related services and facilitation of production and management of mortgage loans. In addition, the company offers annuity and life insurance products, such as deferred and immediate annuities, as well as indexed universal life insurance products; and funding agreements and pension risk transfer (PRT) solutions. Further, it engages in the real estate brokerage business. Fidelity National Financial, Inc. was incorporated in 2005 and is headquartered in Jacksonville, Florida.
More stocks
- WH Group Ltd (288.HK)
- Allwyn AG (ALWN.AT)
- Pharmaron Beijing Co Ltd (300759.SZ)
- Avantor, Inc. (AVTR)
- Shoprite Holdings Ltd (SHP.JO)
- AES Corporation (AES)
- Goertek Inc (002241.SZ)
- Absa Group Ltd (ABG.JO)
- Eiffage SA (FGR.PA)
- Yara International ASA (YAR.OL)
- Petro Rio S.A. (PRIO3.SA)
- MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.